Absci Investor Presentation Deck

DE NOVO ANTIBODY DESIGN IN SILICO In silico validation of Zero-shot designs toward diverse targets Al-generated Heavy Chain Al-generated Light Chain Known binder structure¹ Antigen ¹Known binder crystal structures are literature sourced Prostaglandin E receptor EP4, GPCR, Fab (5YHL) ABSCI CORPORATION 2023 ALL RIGHTS RESERVED 윤 S. aureus a-hemolysin monomer, Fab (4IDJ) P. vivax RBP2b, monoclonal (6WOZ) Pekin duck egg lysozyme, Fab (5VJQ) Human urokinase receptor (2FD6) absci. 18

View entire presentation